+20.1%
GSK vs VIK
+34.6%
-14.4%
-19.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | VIK | Excess | Alpha |
|---|---|---|---|---|
| 1D | 0.0% | +1.2% | -1.2% | -0.2% |
| 7D | -3.5% | -0.9% | -2.6% | -3.4% |
| 30D | -3.4% | -18.4% | +15.0% | -0.4% |
| 3M | -8.1% | -8.8% | +0.6% | -7.2% |
| 6M | -11.1% | +17.1% | -28.3% | -14.6% |
| YTD | +0.7% | +19.0% | -18.3% | -3.6% |
| 1Y | +20.1% | +30.1% | -10.0% | +16.2% |
| All | +20.1% | +34.6% | -14.4% | +16.2% |
Cumulative growth
Daily Returns
Daily percentage return beside VIK.
Daily Out/Under-Performance
Portfolio return minus VIK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VIK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded VIK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling